Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
80.28
-3.84 (-4.56%)
Feb 21, 2025, 4:00 PM EST - Market closed
Globus Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 784.44 | 467.29 | 150.47 | 193.07 | 239.4 | Upgrade
|
Short-Term Investments | 105.62 | 50.5 | 295.59 | 250.38 | 187.34 | Upgrade
|
Cash & Short-Term Investments | 890.06 | 517.79 | 446.06 | 443.45 | 426.74 | Upgrade
|
Cash Growth | 71.90% | 16.08% | 0.59% | 3.91% | 37.00% | Upgrade
|
Accounts Receivable | 557.7 | 503.24 | 213.25 | 164.44 | 141.68 | Upgrade
|
Other Receivables | 20.63 | 1.64 | 4.06 | 1.22 | 6.42 | Upgrade
|
Receivables | 578.33 | 504.87 | 217.31 | 165.65 | 148.1 | Upgrade
|
Inventory | 659.23 | 848.14 | 298.98 | 237 | 229.15 | Upgrade
|
Prepaid Expenses | 49.64 | 44.58 | 21 | 18.42 | 17.77 | Upgrade
|
Total Current Assets | 2,177 | 1,915 | 983.34 | 864.52 | 821.77 | Upgrade
|
Property, Plant & Equipment | 611.56 | 647.66 | 249.72 | 221.08 | 221.62 | Upgrade
|
Long-Term Investments | 66.13 | 75.43 | 495.85 | 562.48 | 358.52 | Upgrade
|
Goodwill | 1,432 | 1,435 | 197.47 | 179.71 | 156.72 | Upgrade
|
Other Intangible Assets | 795.12 | 924.6 | 63.57 | 68.66 | 86.95 | Upgrade
|
Long-Term Deferred Tax Assets | 94.2 | 10.69 | 48.85 | 24.49 | 6.62 | Upgrade
|
Other Long-Term Assets | 75.1 | 77.79 | 37.32 | 36.33 | 27.3 | Upgrade
|
Total Assets | 5,252 | 5,086 | 2,076 | 1,957 | 1,679 | Upgrade
|
Accounts Payable | 75.12 | 56.67 | 36.1 | 21.96 | 18.21 | Upgrade
|
Accrued Expenses | 260.59 | 230.65 | 86.61 | 87.24 | 85.07 | Upgrade
|
Current Portion of Long-Term Debt | 443.35 | - | - | - | - | Upgrade
|
Current Portion of Leases | 10.25 | 12.44 | 2.54 | - | 1.87 | Upgrade
|
Current Income Taxes Payable | 10.73 | 3.85 | 0.99 | 1.05 | 1.1 | Upgrade
|
Current Unearned Revenue | 22.14 | 18.37 | 14.1 | 12.03 | 8.13 | Upgrade
|
Other Current Liabilities | 33.74 | 70.37 | 18.87 | 17.89 | 6.43 | Upgrade
|
Total Current Liabilities | 855.91 | 392.35 | 159.2 | 140.16 | 120.79 | Upgrade
|
Long-Term Debt | - | 417.4 | - | - | - | Upgrade
|
Long-Term Leases | 83.59 | 91.37 | 3.48 | - | 2.94 | Upgrade
|
Long-Term Deferred Tax Liabilities | 23.89 | 84.42 | 1.78 | 4.31 | 6.2 | Upgrade
|
Other Long-Term Liabilities | 111.03 | 102.58 | 65.3 | 71.4 | 43.26 | Upgrade
|
Total Liabilities | 1,074 | 1,088 | 229.75 | 215.88 | 173.19 | Upgrade
|
Common Stock | 0.14 | 0.14 | 0.1 | 0.1 | 0.1 | Upgrade
|
Additional Paid-In Capital | 3,031 | 2,871 | 630.95 | 553.79 | 457.16 | Upgrade
|
Retained Earnings | 1,153 | 1,137 | 1,240 | 1,194 | 1,045 | Upgrade
|
Comprehensive Income & Other | -6.86 | -10.19 | -24.63 | -6.77 | 3.96 | Upgrade
|
Shareholders' Equity | 4,177 | 3,998 | 1,846 | 1,741 | 1,506 | Upgrade
|
Total Liabilities & Equity | 5,252 | 5,086 | 2,076 | 1,957 | 1,679 | Upgrade
|
Total Debt | 537.19 | 521.22 | 6.01 | - | 4.8 | Upgrade
|
Net Cash (Debt) | 419 | 72 | 935.9 | 1,006 | 780.46 | Upgrade
|
Net Cash Growth | 481.94% | -92.31% | -6.96% | 28.89% | 8.62% | Upgrade
|
Net Cash Per Share | 3.04 | 0.63 | 9.12 | 9.71 | 7.73 | Upgrade
|
Filing Date Shares Outstanding | 137.42 | 135.37 | 100.3 | 101.56 | 99.8 | Upgrade
|
Total Common Shares Outstanding | 137.42 | 136.34 | 100.19 | 101.54 | 99.71 | Upgrade
|
Working Capital | 1,321 | 1,523 | 824.14 | 724.35 | 700.97 | Upgrade
|
Book Value Per Share | 30.40 | 29.32 | 18.43 | 17.15 | 15.11 | Upgrade
|
Tangible Book Value | 1,950 | 1,639 | 1,585 | 1,493 | 1,263 | Upgrade
|
Tangible Book Value Per Share | 14.19 | 12.02 | 15.82 | 14.70 | 12.66 | Upgrade
|
Land | - | 9.75 | 8.28 | 8.3 | 8.32 | Upgrade
|
Buildings | - | 102.45 | 51.51 | 44.67 | 33.83 | Upgrade
|
Machinery | - | 878.41 | 508.88 | 443.25 | 423.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.